Study on Point Use Rules of Acupuncture and Moxibustion Treating Neurogenic Bowel Dysfunction After Spinal Cord Injury Based on Ancient and Modern Medical Record Cloud Platform
Abstract:Objective:Based on the Ancient and Modern Medical Record Cloud Platform,clinical literature was excavated to explore the point use rules of modern acupuncture and moxibustion in the treatment of neurogenic bowel dysfunction after spinal cord injury. Methods:The clinical research literature on acupuncture and moxibustion in the treatment of neurogenic bowel dysfunction after spinal cord injury were searched and collected in China National Knowledge Infrastructure,Wanfang Med Online, VIP Database and PubMed Database. Point prescriptions and other relevant information were sorted out and standardized;Ancient and Modern Medical Record Cloud Platform v2 2.3 was used to processes the data;core points and combination rules were analyzed and visually displayed. Results : A total of 37 literature were enrolled , involving 40 acupuncture and moxibustion prescriptions and 47 points including 45 channel points and 2 extra points. Points with high frequency were Tianshu point, Zusanli point, Zhigou point, Shangjuxu point, Zhongwan point, Guanyuan point, Dachangshu point, Shenque point and Qihai point. The foot yangming stomach channel, ren mai, and the foot taiyang bladder channel were widely used in treatment. The frequency of points on yang channel was significantly higher than that of points on yin channel. Based on the analysis of use frequency and association rules of point combinations,it was concluded that common point combinations included Tianshu point and Zhigou point,Tianshu point and Shangjuxu point,and Tianshu point and Zhongwan point. Conclusion: Characteristics of point use of acupuncture and moxibustion in the treatment of neurogenic bowel dysfunction after spinal cord injury summarized by using Ancient and Modern Medical Record Cloud Platform can provide the basis and reference scheme of point selection and prescription for the clinical treatment of this disease.